ID   CD11B_HUMAN             Reviewed;         795 AA.
AC   P21127; O95265; Q12817; Q12818; Q12819; Q12820; Q12822; Q8N530;
AC   Q9NZS5; Q9UBJ0; Q9UBQ1; Q9UBR0; Q9UNY2; Q9UP57; Q9UP58; Q9UP59;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2003, sequence version 3.
DT   05-OCT-2010, entry version 124.
DE   RecName: Full=Cell division protein kinase 11B;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division cycle 2-like protein kinase 1;
DE            Short=CLK-1;
DE   AltName: Full=Galactosyltransferase-associated protein kinase p58/GTA;
DE   AltName: Full=PITSLRE serine/threonine-protein kinase CDC2L1;
DE   AltName: Full=p58 CLK-1;
GN   Name=CDK11B; Synonyms=CDC2L1, CDK11, PITSLREA, PK58;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), AND FUNCTION.
RC   TISSUE=Liver;
RX   MEDLINE=91017527; PubMed=2217177; DOI=10.1073/pnas.87.19.7467;
RA   Bunnell B.A., Heath L.S., Adams D.E., Lahti J.M., Kidd V.J.;
RT   "Increased expression of a 58-kDa protein kinase leads to changes in
RT   the CHO cell cycle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7467-7471(1990).
RN   [2]
RP   ERRATUM, AND SEQUENCE REVISION.
RX   MEDLINE=91172857; PubMed=2006197; DOI=10.1073/pnas.88.6.2612a;
RA   Bunnell B.A., Heath L.S., Adams D.E., Lahti J.M., Kidd V.J.;
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2612-2612(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 7), AND VARIANT GLN-601.
RC   TISSUE=Hematopoietic;
RX   MEDLINE=92347856; PubMed=1639388; DOI=10.1016/0888-7543(92)90132-C;
RA   Eipers P.G., Lahti J.M., Kidd V.J.;
RT   "Structure and expression of the human p58clk-1 protein kinase
RT   chromosomal gene.";
RL   Genomics 13:613-621(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS SV1; 2; 3; 8 AND SV11), VARIANT
RP   CYS-57, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=94253170; PubMed=8195233;
RA   Xiang J., Lahti J.M., Grenet J.A., Easton J.B., Kidd V.J.;
RT   "Molecular cloning and expression of alternatively spliced PITSLRE
RT   protein kinase isoforms.";
RL   J. Biol. Chem. 269:15786-15794(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS SV1; SV4; SV5; SV9;
RP   SV10 AND SV11), AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=98424414; PubMed=9750192;
RA   Gururajan R., Lahti J.M., Grenet J.A., Easton J., Gruber I.,
RA   Ambros P.F., Kidd V.J.;
RT   "Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22
RT   genes on human chromosome 1p36.3 and their linkage to D1Z2.";
RL   Genome Res. 8:929-939(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV11).
RC   TISSUE=Placenta;
RA   Govindan M.V., Warriar N.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INTERACTION WITH RNPS1.
RX   MEDLINE=98248436; PubMed=9580558;
RA   Loyer P., Trembley J.H., Lahti J.M., Kidd V.J.;
RT   "The RNP protein, RNPS1, associates with specific isoforms of the
RT   p34cdc2-related PITSLRE protein kinases in vivo.";
RL   J. Cell Sci. 111:1495-1506(1998).
RN   [8]
RP   ALTERNATIVE INITIATION (ISOFORM 7), AND INDUCTION.
RX   MEDLINE=20337944; PubMed=10882096; DOI=10.1016/S1097-2765(00)80239-7;
RA   Cornelis S., Bruynooghe Y., Denecker G., Van Huffel S., Tinton S.,
RA   Beyaert R.;
RT   "Identification and characterization of a novel cell cycle-regulated
RT   internal ribosome entry site.";
RL   Mol. Cell 5:597-605(2000).
RN   [9]
RP   INTERACTION WITH RANBP9, AUTOPHOSPHORYLATION, AND SUBCELLULAR
RP   LOCATION.
RX   MEDLINE=22873251; PubMed=14511641; DOI=10.1016/j.bbrc.2003.08.116;
RA   Mikolajczyk M., Shi J., Vaillancourt R.R., Sachs N.A., Nelson M.;
RT   "The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM.";
RL   Biochem. Biophys. Res. Commun. 310:14-18(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CCNL1 AND SFRS7.
RX   MEDLINE=22499644; PubMed=12501247; DOI=10.1074/jbc.M210057200;
RA   Hu D., Mayeda A., Trembley J.H., Lahti J.M., Kidd V.J.;
RT   "CDK11 complexes promote pre-mRNA splicing.";
RL   J. Biol. Chem. 278:8623-8629(2003).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH PAK1.
RX   MEDLINE=22651041; PubMed=12624090; DOI=10.1074/jbc.M300818200;
RA   Chen S., Yin X., Zhu X., Yan J., Ji S., Chen C., Cai M., Zhang S.,
RA   Zong H., Hu Y., Yuan Z., Shen Z., Gu J.;
RT   "The C-terminal kinase domain of the p34cdc2-related PITSLRE protein
RT   kinase (p110C) associates with p21-activated kinase 1 and inhibits its
RT   activity during anoikis.";
RL   J. Biol. Chem. 278:20029-20036(2003).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283; SER-589 AND
RP   THR-595, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283 AND THR-595, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47 AND SER-234, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-381; SER-384;
RP   THR-395; SER-410; SER-414; TYR-594 AND THR-595, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-595, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283; SER-589; THR-595;
RP   THR-751 AND SER-752, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-57; TRP-201; LEU-414; ALA-452;
RP   VAL-463; SER-506; GLN-601; ASN-641 AND VAL-670.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Appears to play multiple roles in cell cycle
CC       progression, cytokinesis and apoptosis. The p110 isoforms have
CC       been suggested to be involved in pre-mRNA splicing, potentially by
CC       phosphorylating the splicing protein SFRS7. The p58 isoform may
CC       act as a negative regulator of normal cell cycle progression.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Phosphorylation at Thr-448 or Tyr-449
CC       inactivates the enzyme, while phosphorylation at Thr-595 activates
CC       it (By similarity).
CC   -!- SUBUNIT: The cleaved p110 isoform, p110C, binds to the
CC       serine/threonine kinase PAK1 and RANBP9. p110C interacts with
CC       RNPS1. The p58 isoform but not the p110 isoforms or p110C
CC       interacts with CCND3. The p110 isoforms are found in large
CC       molecular weight complexes containing CCNL1 and SFRS7.
CC   -!- INTERACTION:
CC       Q13153:PAK1; NbExp=2; IntAct=EBI-1298, EBI-1307;
CC       Q15287:RNPS1; NbExp=1; IntAct=EBI-1298, EBI-395959;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=10;
CC       Name=SV9; Synonyms=p110;
CC         IsoId=P21127-1; Sequence=Displayed;
CC       Name=SV1; Synonyms=Alpha 2-1;
CC         IsoId=P21127-2; Sequence=VSP_008280;
CC       Name=2; Synonyms=Alpha 2-2;
CC         IsoId=P21127-3; Sequence=VSP_008278, VSP_008279, VSP_008280;
CC       Name=3; Synonyms=Alpha 1;
CC         IsoId=P21127-4; Sequence=VSP_008276;
CC       Name=SV4;
CC         IsoId=P21127-5; Sequence=VSP_008275;
CC       Name=SV5;
CC         IsoId=P21127-6; Sequence=VSP_008273, VSP_008277, VSP_008278,
CC                                  VSP_008280;
CC       Name=8; Synonyms=Alpha 2-3;
CC         IsoId=P21127-8; Sequence=VSP_008278, VSP_008280;
CC       Name=SV10;
CC         IsoId=P21127-9; Sequence=VSP_008273, VSP_008277, VSP_008280;
CC       Name=SV11; Synonyms=Alpha 2-4;
CC         IsoId=P21127-10; Sequence=VSP_008274, VSP_008280;
CC       Name=7; Synonyms=p58;
CC         IsoId=P21127-12; Sequence=VSP_018834;
CC         Note=Produced by alternative initiation at Met-357 of isoform
CC         SV9;
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously. Some evidence of
CC       isoform-specific tissue distribution.
CC   -!- INDUCTION: The p58 isoform is specifically induced in G2/M phase
CC       of the cell cycle.
CC   -!- PTM: During apoptosis, induced by Fas or tumor necrosis factor,
CC       specific CKD11 p110 isoforms are cleaved by caspases to produce a
CC       protein (p110C) that contains the C-terminal kinase domain of the
CC       CDK11 proteins.
CC   -!- PTM: p110C can be autophosphorylated.
CC   -!- MISCELLANEOUS: Duplicated gene. CDK11A and CDK11B encode almost
CC       identical protein kinases of 110 kDa that contain at their C-
CC       termini the open reading frame of a smaller 58 kDa isoform which
CC       is expressed following IRES-mediated alternative initiation of
CC       translation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- CAUTION: Many references talk about 'p110 isoforms' but it is not
CC       yet known if this refers to CDK11A and/or CDK11B or one/some of
CC       the isoforms of each.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC83664.1; Type=Erroneous gene model prediction;
CC       Sequence=AAF36538.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M37712; AAA36406.1; ALT_SEQ; mRNA.
DR   EMBL; M88563; AAB59449.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M88553; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88554; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88555; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88558; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88559; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88560; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88561; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; M88562; AAB59449.1; JOINED; Genomic_DNA.
DR   EMBL; U04815; AAA19581.1; -; mRNA.
DR   EMBL; U04816; AAA19582.1; -; mRNA.
DR   EMBL; U04817; AAA19583.1; -; mRNA.
DR   EMBL; U04818; AAA19584.1; -; mRNA.
DR   EMBL; U04824; AAA19586.1; -; mRNA.
DR   EMBL; AF067512; AAC72077.1; -; mRNA.
DR   EMBL; AF067513; AAC72078.1; -; mRNA.
DR   EMBL; AF067514; AAC72079.1; -; mRNA.
DR   EMBL; AF067515; AAC72080.1; -; mRNA.
DR   EMBL; AF067516; AAC72081.1; -; mRNA.
DR   EMBL; AF067517; AAC72082.1; -; mRNA.
DR   EMBL; AF080683; AAC83662.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83662.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83663.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83663.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83664.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF080685; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83664.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83665.1; -; Genomic_DNA.
DR   EMBL; AF080685; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080686; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080687; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080688; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF092429; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF092430; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83665.1; JOINED; Genomic_DNA.
DR   EMBL; AF080683; AAC83666.1; -; Genomic_DNA.
DR   EMBL; AF092430; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080678; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080679; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080680; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080681; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF080682; AAC83666.1; JOINED; Genomic_DNA.
DR   EMBL; AF174497; AAF36538.1; ALT_INIT; mRNA.
DR   IPI; IPI00071185; -.
DR   IPI; IPI00071188; -.
DR   IPI; IPI00215999; -.
DR   IPI; IPI00337617; -.
DR   IPI; IPI00376979; -.
DR   IPI; IPI00376980; -.
DR   IPI; IPI00376983; -.
DR   IPI; IPI00395687; -.
DR   IPI; IPI00736011; -.
DR   IPI; IPI00759690; -.
DR   PIR; A38282; A38282.
DR   PIR; B54024; B54024.
DR   PIR; E54024; E54024.
DR   PIR; F54024; F54024.
DR   PIR; H54024; H54024.
DR   PIR; T09568; T09568.
DR   RefSeq; NP_277021.1; -.
DR   RefSeq; NP_277022.1; -.
DR   RefSeq; NP_277023.1; -.
DR   RefSeq; NP_277024.1; -.
DR   RefSeq; NP_277027.1; -.
DR   RefSeq; NP_277028.1; -.
DR   UniGene; Hs.651228; -.
DR   UniGene; Hs.709182; -.
DR   ProteinModelPortal; P21127; -.
DR   SMR; P21127; 441-736.
DR   DIP; DIP-29015N; -.
DR   IntAct; P21127; 8.
DR   MINT; MINT-1400900; -.
DR   STRING; P21127; -.
DR   PhosphoSite; P21127; -.
DR   PRIDE; P21127; -.
DR   Ensembl; ENST00000341028; ENSP00000344418; ENSG00000008128.
DR   Ensembl; ENST00000378633; ENSP00000367900; ENSG00000008128.
DR   Ensembl; ENST00000401097; ENSP00000383875; ENSG00000008128.
DR   GeneID; 984; -.
DR   KEGG; hsa:984; -.
DR   UCSC; uc001ags.1; human.
DR   CTD; 984; -.
DR   GeneCards; GC01M001572; -.
DR   HGNC; HGNC:1729; CDK11B.
DR   HPA; CAB010467; -.
DR   MIM; 176873; gene.
DR   PharmGKB; PA26262; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P21127; -.
DR   PhylomeDB; P21127; -.
DR   BRENDA; 2.7.11.22; 247.
DR   Pathway_Interaction_DB; ar_pathway; Coregulation of Androgen receptor activity.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   NextBio; 4128; -.
DR   PMAP-CutDB; P21127; -.
DR   ArrayExpress; P21127; -.
DR   Bgee; P21127; -.
DR   Genevestigator; P21127; -.
DR   GermOnline; ENSG00000008128; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; IEA:EC.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0006915; P:apoptosis; NAS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0007067; P:mitosis; NAS:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; IEP:UniProtKB.
DR   GO; GO:0050684; P:regulation of mRNA processing; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; NAS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Alternative splicing; Apoptosis; ATP-binding;
KW   Cell cycle; Complete proteome; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    795       Cell division protein kinase 11B.
FT                                /FTId=PRO_0000024311.
FT   DOMAIN      438    723       Protein kinase.
FT   NP_BIND     444    452       ATP (By similarity).
FT   COMPBIAS    126    393       Glu-rich.
FT   ACT_SITE    562    562       Proton acceptor (By similarity).
FT   BINDING     467    467       ATP (By similarity).
FT   MOD_RES      47     47       Phosphoserine.
FT   MOD_RES      65     65       Phosphoserine.
FT   MOD_RES     234    234       Phosphoserine.
FT   MOD_RES     277    277       Phosphoserine (By similarity).
FT   MOD_RES     283    283       Phosphoserine.
FT   MOD_RES     381    381       Phosphoserine.
FT   MOD_RES     384    384       Phosphoserine.
FT   MOD_RES     395    395       Phosphothreonine.
FT   MOD_RES     410    410       Phosphoserine.
FT   MOD_RES     414    414       Phosphoserine.
FT   MOD_RES     448    448       Phosphothreonine (By similarity).
FT   MOD_RES     449    449       Phosphotyrosine (By similarity).
FT   MOD_RES     589    589       Phosphoserine.
FT   MOD_RES     594    594       Phosphotyrosine.
FT   MOD_RES     595    595       Phosphothreonine.
FT   MOD_RES     751    751       Phosphothreonine.
FT   MOD_RES     752    752       Phosphoserine.
FT   VAR_SEQ       1    356       Missing (in isoform 7).
FT                                /FTId=VSP_018834.
FT   VAR_SEQ       1    269       Missing (in isoform SV4).
FT                                /FTId=VSP_008275.
FT   VAR_SEQ       1    217       Missing (in isoform SV11).
FT                                /FTId=VSP_008274.
FT   VAR_SEQ       1     34       Missing (in isoform SV5 and isoform
FT                                SV10).
FT                                /FTId=VSP_008273.
FT   VAR_SEQ       2    335       Missing (in isoform 3).
FT                                /FTId=VSP_008276.
FT   VAR_SEQ      35     37       LKN -> MSQ (in isoform SV5 and isoform
FT                                SV10).
FT                                /FTId=VSP_008277.
FT   VAR_SEQ     110    119       Missing (in isoform 2, isoform SV5 and
FT                                isoform 8).
FT                                /FTId=VSP_008278.
FT   VAR_SEQ     165    165       R -> RGNDGVCLFR (in isoform 2).
FT                                /FTId=VSP_008279.
FT   VAR_SEQ     252    265       GEARPARAQKPAQL -> V (in isoform SV1,
FT                                isoform 2, isoform SV5, isoform 8,
FT                                isoform SV10 and isoform SV11).
FT                                /FTId=VSP_008280.
FT   VARIANT      57     57       R -> C (in dbSNP:rs17424353).
FT                                /FTId=VAR_041958.
FT   VARIANT      93     93       R -> W (in dbSNP:rs1059831).
FT                                /FTId=VAR_057775.
FT   VARIANT     109    109       R -> C (in dbSNP:rs1059830).
FT                                /FTId=VAR_062199.
FT   VARIANT     201    201       R -> W.
FT                                /FTId=VAR_041959.
FT   VARIANT     414    414       S -> L.
FT                                /FTId=VAR_041960.
FT   VARIANT     452    452       V -> A.
FT                                /FTId=VAR_045577.
FT   VARIANT     463    463       I -> V.
FT                                /FTId=VAR_041961.
FT   VARIANT     506    506       G -> S.
FT                                /FTId=VAR_045578.
FT   VARIANT     601    601       L -> Q.
FT                                /FTId=VAR_041962.
FT   VARIANT     641    641       K -> N.
FT                                /FTId=VAR_041963.
FT   VARIANT     670    670       A -> V (in dbSNP:rs1059811).
FT                                /FTId=VAR_041964.
FT   CONFLICT    109    109       Missing (in Ref. 4; AAA19582/AAA19583 and
FT                                5; AAC72079).
FT   CONFLICT    126    126       E -> K (in Ref. 4; AAA19582/AAA19583/
FT                                AAA19586).
FT   CONFLICT    320    320       S -> T (in Ref. 6).
FT   CONFLICT    324    326       Missing (in Ref. 4; AAA19582/AAA19583/
FT                                AAA19584/AAA19586).
FT   CONFLICT    436    436       E -> D (in Ref. 3).
FT   CONFLICT    560    560       H -> Q (in Ref. 6).
FT   CONFLICT    567    567       N -> T (in Ref. 6).
FT   CONFLICT    678    678       E -> R (in Ref. 4 and 6).
FT   CONFLICT    694    694       D -> E (in Ref. 3).
FT   CONFLICT    697    697       F -> C (in Ref. 6).
FT   CONFLICT    712    712       I -> L (in Ref. 3).
FT   CONFLICT    715    715       E -> Q (in Ref. 3).
FT   CONFLICT    792    792       S -> R (in Ref. 6).
SQ   SEQUENCE   795 AA;  92707 MW;  C07CEE9A4F7A6804 CRC64;
     MGDEKDSWKV KTLDEILQEK KRRKEQEEKA EIKRLKNSDD RDSKRDSLEE GELRDHRMEI
     TIRNSPYRRE DSMEDRGEED DSLAIKPPQQ MSRKEKVHHR KDEKRKEKRR HRSHSAEGGK
     HARVKEKERE HERRKRHREE QDKARREWER QKRREMAREH SRRERDRLEQ LERKRERERK
     MREQQKEQRE QKERERRAEE RRKEREARRE VSAHHRTMRE DYSDKVKASH WSRSPPRPPR
     ERFELGDGRK PGEARPARAQ KPAQLKEEKM EERDLLSDLQ DISDSERKTS SAESSSAESG
     SGSEEEEEEE EEEEEEGSTS EESEEEEEEE EEEEEETGSN SEEASEQSAE EVSEEEMSED
     EERENENHLL VVPESRFDRD SGESEEAEEE VGEGTPQSSA LTEGDYVPDS PALSPIELKQ
     ELPKYLPALQ GCRSVEEFQC LNRIEEGTYG VVYRAKDKKT DEIVALKRLK MEKEKEGFPI
     TSLREINTIL KAQHPNIVTV REIVVGSNMD KIYIVMNYVE HDLKSLMETM KQPFLPGEVK
     TLMIQLLRGV KHLHDNWILH RDLKTSNLLL SHAGILKVGD FGLAREYGSP LKAYTPVVVT
     LWYRAPELLL GAKEYSTAVD MWSVGCIFGE LLTQKPLFPG KSEIDQINKV FKDLGTPSEK
     IWPGYSELPA VKKMTFSEHP YNNLRKRFGA LLSDQGFDLM NKFLTYFPGR RISAEDGLKH
     EYFRETPLPI DPSMFPTWPA KSEQQRVKRG TSPRPPEGGL GYSQLGDDDL KETGFHLTTT
     NQGASAAGPG FSLKF
//
